Category: ROOT

Children's hospitals brace for aftermath of holiday gatherings

While respiratory syncytial virus and the flu may have peaked, hospitals are still seeing high numbers of ill patients, and there is no telling whether holiday gatherings will reverse the plateau, CNN reported Dec. 21. 

Joint Commission to overhaul quality metrics, freeze accreditation fees: 6 changes for 2023

The Joint Commission is undergoing sweeping overhaul of its standards, eliminating 168 standards (14 percent) and revising another 14 standards. The commission is looking to make its accreditation programs as “efficient and impactful on patient safety,…

6 in 10 say more price transparency laws should be 'top priority' for Congress: poll

A majority of Americans say further price transparency fixes should be a “top priority” for Congress, a Kaiser Family Foundation poll found. 

4 financial trends that will drive health system decisions in 2023: Deloitte

Health system leaders are expecting healthcare decisions in 2023 to be defined by staffing challenges, inflation, patient affordability, shrinking margins and supply chain struggles, according to a recent Deloitte Center for Health Solutions survey.

52% of patients say their symptoms are ignored: survey 

Fifty-two percent of U.S. patients said healthcare providers dismiss their described symptoms, according to a new MITRE-Harris poll.

5 health systems seeking revenue cycle vice presidents

Five health systems recently posted job listings seeking revenue cycle vice presidents. 

CEO of St. Peter's Health Partners to retire Dec. 31

James Reed, MD, president and CEO of Albany, N.Y.-based St. Peter’s Health Partners and Syracuse, N.Y.-based St. Joseph’s Health, will retire December 31.

Surgeons invest $4M for ownership stake in New York ASC

Surgeons have invested $4 million for 50 percent ownership in an Amherst, N.Y.-based ASC, Buffalo Business First reported Dec. 21.

Paxlovid worth 80% less, healthcare market research group says

As drugmakers prepare for the government to stop paying for their COVID-19 treatments, the value of Pfizer’s popular COVID-19 drug Paxlovid has decreased by more than 80 percent, according to the Institute for Clinical and Economic Review. 

Healthcare companies face wall of maturing debt amid cash shortage

Not only do healthcare companies, including hospital groups, face sustained challenges related to labor shortages and inflation into 2023, they are up against a wall of maturing debt looming large in 2024 and 2025, analysts at Moody’s said.